Lisa Leonard
Payments from drug & device makers
Across 125 payments — averaging $16.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$433
- Lilly USA, LLC$140
- AbbVie$123
- AstraZeneca$116
- Abbott$113
- Amgen$105
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,107100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 27 | $433 |
| Lilly USA, LLC | 7 | $140 |
| AbbVie | 6 | $123 |
| AstraZeneca | 6 | $116 |
| Abbott | 6 | $113 |
| Amgen | 7 | $105 |
| GSK | 6 | $104 |
| Astellas Pharma US Inc | 7 | $102 |
| Pfizer | 5 | $101 |
| Merck | 6 | $85 |
| Xeris Pharmaceuticals, Inc. | 5 | $81 |
| Johnson & Johnson | 5 | $76 |
| Novartis | 4 | $58 |
| Medtronic | 2 | $50 |
| Boehringer Ingelheim | 4 | $49 |
| Exact Sciences | 2 | $45 |
| Biohaven Pharmaceuticals, Inc. | 3 | $43 |
| Sanofi Pasteur Inc. | 2 | $38 |
| Microtransponder, Inc. | 1 | $34 |
| Dexcom, Inc. | 2 | $27 |
| Genentech USA, Inc. | 2 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Mylan Specialty L.p. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Watermark Medical, Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $14 |
How this compares
$2,107 in reported general payments places this provider in the 75th percentile of 523 family providers in Delaware.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 65 | $96,996 |
| MounjaroTirzepatide | 44 | $77,074 |
| JardianceEmpagliflozin | 51 | $61,379 |
| TrulicityDulaglutide | 15 | $31,044 |
| JanuviaSitagliptin Phosphate | 15 | $26,767 |
| LinzessLinaclotide | 17 | $20,773 |
| EliquisApixaban | 16 | $10,675 |
| MyrbetriqMirabegron | 11 | $6,143 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $4,874 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $3,364 |
| Qvar RedihalerBeclomethasone Dipropionate | 12 | $3,191 |
| Atorvastatin Calcium | 238 | $2,799 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $2,189 |
| Rosuvastatin Calcium | 102 | $1,937 |
| Losartan Potassium | 164 | $1,754 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $140 | $108,11759 claims |
| Novo NordiskOzempic | $433 | $96,99665 claims |
| Boehringer IngelheimJardiance | $49 | $61,37951 claims |
| MerckJanuvia | $85 | $26,76715 claims |
| AbbVieLinzess, Synthroid | $123 | $21,54042 claims |
| PfizerEliquis | $101 | $10,67516 claims |
| Astellas Pharma US IncMyrbetriq | $102 | $6,14311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 523 family providers in Delaware.
Other family in Dover
- Heather GrahamDover$6K
- Shannon CullinDover$5K
- Amanda BooneDover$5K
- Tina VarugheseDover$3K
- Patricia PowellDover$3K
- Brandi GreggeMiddletown$110K
- Tracy EstesWilmington$59K
- Kathy GallagherNewark$53K
- Jodie DelesioNewark$50K
- Abby AllenGeorgetown$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.